Loss of CD44 Attenuates Aberrant GM-CSF Signaling in Kras G12D Hematopoietic Progenitor/precursor Cells and Prolongs the Survival of Diseased Animals

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2012 Sep 15

PMID 22976127

Citations 14

Authors

J Du

Y Liu

B Meline

G Kong

L X Tan

J C Lo

J Wang

E Ranheim

L Zhang

Y I Chang

M J Ryu

J F Zhang

J Zhang

Affiliations

Soon will be listed here.

Citing Articles

A translational perspective of the malignant hematopoietic proteoglycome.

Borghini N, Lazzaretti M, Lunghi P, Malpeli G, Barbi S, Perris R Cell Biosci. 2025; 15(1):25.

PMID: 39980017 PMC: 11844096. DOI: 10.1186/s13578-025-01360-7.

Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation.

You X, Liu F, Binder M, Vedder A, Lasho T, Wen Z Blood. 2021; 139(7):1066-1079.

PMID: 34699595 PMC: 8854684. DOI: 10.1182/blood.2021012519.

Nras Q61R/+ and Kras-/- cooperate to downregulate Rasgrp1 and promote lympho-myeloid leukemia in early T-cell precursors.

Wen Z, Yun G, Hebert A, Kong G, Ranheim E, Finn R Blood. 2021; 137(23):3259-3271.

PMID: 33512434 PMC: 8351901. DOI: 10.1182/blood.2020009082.

CD44 Expression Profile Varies According to Maturational Subtypes and Molecular Profiles of Pediatric T-Cell Lymphoblastic Leukemia.

Marques L, Noronha E, Andrade F, Dos Santos-Bueno F, Mansur M, Terra-Granado E Front Oncol. 2018; 8:488.

PMID: 30430079 PMC: 6220090. DOI: 10.3389/fonc.2018.00488.

Downregulating Notch counteracts Kras-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm.

Kong G, You X, Wen Z, Chang Y, Qian S, Ranheim E Leukemia. 2018; 33(3):671-685.

PMID: 30206308 PMC: 6405304. DOI: 10.1038/s41375-018-0248-0.

References

Shi M, Dennis K, Peschon J, Chandrasekaran R, Mikecz K . Antibody-induced shedding of CD44 from adherent cells is linked to the assembly of the cytoskeleton. J Immunol. 2001; 167(1):123-31. DOI: 10.4049/jimmunol.167.1.123. View

Jin L, Hope K, Zhai Q, Smadja-Joffe F, Dick J . Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med. 2006; 12(10):1167-74. DOI: 10.1038/nm1483. View

Krause D, Lazarides K, von Andrian U, Van Etten R . Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat Med. 2006; 12(10):1175-80. DOI: 10.1038/nm1489. View

Protin U, Schweighoffer T, Jochum W, Hilberg F . CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. J Immunol. 1999; 163(9):4917-23. View

Sabnis A, Cheung L, Dail M, Kang H, Santaguida M, Hermiston M . Oncogenic Kras initiates leukemia in hematopoietic stem cells. PLoS Biol. 2009; 7(3):e59. PMC: 2656550. DOI: 10.1371/journal.pbio.1000059. View

Wang J, Liu Y, Li Z, Wang Z, Tan L, Ryu M . Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner. Blood. 2011; 118(2):368-79. PMC: 3138689. DOI: 10.1182/blood-2010-12-326058. View

Zhang J, Wang J, Liu Y, Sidik H, Young K, Lodish H . Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation. Blood. 2008; 113(6):1304-14. PMC: 2637193. DOI: 10.1182/blood-2008-01-134262. View

Chen C, Chang M, Hsieh R, Chang Y, Lin J, Tsan K . Activation of CD44 facilitates DNA repair in T-cell lymphoma but has differential effects on apoptosis induced by chemotherapeutic agents and ionizing radiation. Leuk Lymphoma. 2005; 46(12):1785-95. DOI: 10.1080/10428190500232501. View

Zheng Z, Katoh S, He Q, Oritani K, Miyake K, Lesley J . Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J Cell Biol. 1995; 130(2):485-95. PMC: 2199925. DOI: 10.1083/jcb.130.2.485. View

10.

Cavalcanti Junior G, Savino W, Pombo-de-Oliveira M . CD44 expression in T-cell lymphoblastic leukemia. Braz J Med Biol Res. 1994; 27(9):2259-66. View

11.

Ashworth T, Pear W, Chiang M, Blacklow S, Mastio J, Xu L . Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1. Blood. 2010; 116(25):5455-64. PMC: 3031398. DOI: 10.1182/blood-2010-05-286328. View

12.

Kindler T, Cornejo M, Scholl C, Liu J, Leeman D, Haydu J . K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors. Blood. 2008; 112(8):3373-82. PMC: 2569181. DOI: 10.1182/blood-2008-03-147587. View

13.

Wang J, Liu Y, Li Z, Du J, Ryu M, Taylor P . Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia. Blood. 2010; 116(26):5991-6002. PMC: 3031386. DOI: 10.1182/blood-2010-04-281527. View

14.

Cheng C, Yaffe M, Sharp P . A positive feedback loop couples Ras activation and CD44 alternative splicing. Genes Dev. 2006; 20(13):1715-20. PMC: 1522067. DOI: 10.1101/gad.1430906. View

15.

Ponta H, Sherman L, Herrlich P . CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol. 2003; 4(1):33-45. DOI: 10.1038/nrm1004. View